{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:05:02Z","timestamp":1793851502647,"version":"4.6.1"},"reference-count":53,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>CD4+CD25+Foxp3+ regulatory T cells (Tregs) are pivotal negative regulators of the adaptive immune system. Abnormalities in the number and\/or function of Tregs contribute to the pathogenesis of primary immune thrombocytopenia (ITP). Strategies aimed at modulating Tregs offer potential therapeutic opportunities for ITP management. In this study, we demonstrated that inhibition of cyclin-dependent kinase 8 (CDK8) and CDK19 activity by the small-molecule inhibitor AS2863619 (AS) robustly promoted the conversion of CD4+CD25- effector T cells (Teffs) into CD4+CD25+Foxp3+ Tregs, endowing the converted Tregs with lineage stability and potent suppressive capacity. Mechanistically, AS rapidly augmented STAT5 phosphorylation and subsequent Foxp3 induction. STAT5 blockade completely abrogated this effect, confirming that the Treg-promoting activity of AS was critically dependent on STAT5 signaling. In parallel, AS suppressed STAT3 phosphorylation under interleukin-6\u2013driven conditions, thereby attenuating T helper 17 (Th17) polarization. These mechanistic findings were supported by global transcriptomic analysis, which revealed a profound transcriptional shift by broadly suppressing gene programs of Teff differentiation and function while simultaneously upregulating a robust signature characteristic of stable Tregs. Crucially, unbiased upstream analysis of these changes pinpointed STAT5, STAT3, and FOXP3 as the core transcription factors mediating the drug\u2019s effect. Functional metabolic analysis further revealed that AS mediated metabolic reprogramming in T cells by suppressing glycolysis, thereby providing the necessary metabolic adaptations for Treg conversion. In a murine model of active ITP, CDK8\/CDK19 inhibition elevated Treg frequencies and ameliorated thrombocytopenia in a STAT5-dependent manner. Collectively, our study highlighted the therapeutic potential of CDK8\/CDK19 inhibition in restoring immune homeostasis and managing ITP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031332","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:58:57Z","timestamp":1772477937000},"page":"2114-2131","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["CDK8\/CDK19 inhibition restores T-cell homeostasis in primary immune thrombocytopenia"],"prefix":"10.1182","volume":"147","author":[{"given":"Yan-ming","family":"Wang","sequence":"first","affiliation":[{"name":"1Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"},{"name":"2Department of Hematology, Yantai Yu Huang Ding Hospital, Qingdao University, Yantai, China"},{"name":"3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-qiu","family":"Leng","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-jie","family":"Ma","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Yantai Yu Huang Ding Hospital, Qingdao University, Yantai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-yuan","family":"Li","sequence":"additional","affiliation":[{"name":"3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"5Tianjin Institutes of Health Science, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-sheng","family":"Li","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-tong","family":"Xu","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7331-6776","authenticated-orcid":false,"given":"Shou-qing","family":"Han","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0968-0714","authenticated-orcid":false,"given":"Yu-feng","family":"Gu","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Yantai Yu Huang Ding Hospital, Qingdao University, Yantai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Dong","sequence":"additional","affiliation":[{"name":"6Department of Hematology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-yu","family":"Yan","sequence":"additional","affiliation":[{"name":"7Department of Hematology, North China University of Science and Technology Affiliated Hospital, Tangshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"5Tianjin Institutes of Health Science, Tianjin, China"},{"name":"8School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1434-1490","authenticated-orcid":false,"given":"Jun","family":"Peng","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-guang","family":"Liu","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China"},{"name":"9Shandong Key Laboratory of Hematological Diseases and Immune Microenvironment, Jinan, China"},{"name":"10Shandong Provincial Clinical Research Center for Hematological Diseases, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2026043011220900100_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-023-01401-z","article-title":"How we treat primary immune thrombocytopenia in adults","volume":"16","author":"Liu","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"6","key":"2026043011220900100_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MOH.0000000000000612","article-title":"An update on the pathophysiology of immune thrombocytopenia","volume":"27","author":"Semple","year":"2020","journal-title":"Curr Opin Hematol"},{"issue":"23","key":"2026043011220900100_bib3","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"2","key":"2026043011220900100_bib4","first-page":"103389","article-title":"Regulatory factors involved in Th17\/Treg cell balance of immune thrombocytopenia","volume":"71","author":"Kargar","year":"2023","journal-title":"Curr Res Transl Med"},{"issue":"12","key":"2026043011220900100_bib5","doi-asserted-by":"crossref","first-page":"103677","DOI":"10.1016\/j.autrev.2024.103677","article-title":"Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)","volume":"23","author":"Li","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"14","key":"2026043011220900100_bib6","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1093\/nar\/gkad538","article-title":"CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins","volume":"51","author":"Chen","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2026043011220900100_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2021.11.015","article-title":"MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase","volume":"82","author":"Sooraj","year":"2022","journal-title":"Mol Cell"},{"issue":"11","key":"2026043011220900100_bib8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41580-022-00498-3","article-title":"The Mediator complex as a master regulator of transcription by RNA polymerase II","volume":"23","author":"Richter","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7212","key":"2026043011220900100_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature07179","article-title":"CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity","volume":"455","author":"Firestein","year":"2008","journal-title":"Nature"},{"issue":"35","key":"2026043011220900100_bib10","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1038\/s41388-018-0316-y","article-title":"Mediator kinase CDK8\/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer","volume":"37","author":"Serrao","year":"2018","journal-title":"Oncogene"},{"issue":"38","key":"2026043011220900100_bib11","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1073\/pnas.1710467114","article-title":"CDK8\/19 Mediator kinases potentiate induction of transcription by NF-kB","volume":"114","author":"Chen","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2026043011220900100_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2013.04.048","article-title":"HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia","volume":"153","author":"Galbraith","year":"2013","journal-title":"Cell"},{"key":"2026043011220900100_bib13","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.3389\/fimmu.2019.01988","article-title":"Inhibition of Cdk8\/Cdk19 activity promotes Treg cell differentiation and suppresses autoimmune diseases","volume":"10","author":"Guo","year":"2019","journal-title":"Front Immunol"},{"issue":"40","key":"2026043011220900100_bib14","doi-asserted-by":"crossref","first-page":"eaaw2707","DOI":"10.1126\/sciimmunol.aaw2707","article-title":"Conversion of antigen-specific effector\/memory T cells into Foxp3-expressing Treg cells by inhibition of CDK8\/19","volume":"4","author":"Akamatsu","year":"2019","journal-title":"Sci Immunol"},{"issue":"9","key":"2026043011220900100_bib15","doi-asserted-by":"crossref","first-page":"e0008521","DOI":"10.1128\/MCB.00085-21","article-title":"The cyclin-dependent kinase 8 (CDK8) inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4+ T cells via a novel CDK8-GATA3-FOXP3 pathway","volume":"41","author":"Arnett","year":"2021","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2026043011220900100_bib16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12185-018-2445-z","article-title":"Chinese guidelines for treatment of adult primary immune thrombocytopenia","volume":"107","author":"Liu","year":"2018","journal-title":"Int J Hematol"},{"issue":"1","key":"2026043011220900100_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"19","key":"2026043011220900100_bib18","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-beta signaling in health and disease","volume":"186","author":"Massague","year":"2023","journal-title":"Cell"},{"issue":"7","key":"2026043011220900100_bib19","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","article-title":"Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity","volume":"179","author":"Harris","year":"2007","journal-title":"J Immunol"},{"key":"2026043011220900100_bib20","doi-asserted-by":"crossref","first-page":"12993","DOI":"10.1038\/ncomms12993","article-title":"ICER is requisite for Th17 differentiation","volume":"7","author":"Yoshida","year":"2016","journal-title":"Nat Commun"},{"issue":"5","key":"2026043011220900100_bib21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"issue":"6","key":"2026043011220900100_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","volume":"30","author":"Ohkura","year":"2020","journal-title":"Cell Res"},{"issue":"6","key":"2026043011220900100_bib23","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.celrep.2017.10.058","article-title":"CDK8 kinase activity promotes glycolysis","volume":"21","author":"Galbraith","year":"2017","journal-title":"Cell Rep"},{"issue":"9","key":"2026043011220900100_bib24","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/s41590-020-0725-2","article-title":"Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen","volume":"21","author":"Vardhana","year":"2020","journal-title":"Nat Immunol"},{"issue":"6468","key":"2026043011220900100_bib25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"2026043011220900100_bib26","doi-asserted-by":"crossref","first-page":"155832","DOI":"10.1016\/j.metabol.2024.155832","article-title":"Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects","volume":"155","author":"Xu","year":"2024","journal-title":"Metabolism"},{"issue":"1","key":"2026043011220900100_bib27","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s42003-022-03913-9","article-title":"Blockade of PGK1 and ALDOA enhances bilirubin control of Th17 cells in Crohn\u2019s disease","volume":"5","author":"Vuerich","year":"2022","journal-title":"Commun Biol"},{"issue":"6","key":"2026043011220900100_bib28","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cvr\/cvad029","article-title":"Inhibition of phosphoglycerate kinase 1 attenuates autoimmune myocarditis by reprogramming CD4+ T cell metabolism","volume":"119","author":"Lu","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"5","key":"2026043011220900100_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.03.020","article-title":"A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance","volume":"54","author":"Dikiy","year":"2021","journal-title":"Immunity"},{"issue":"7090","key":"2026043011220900100_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"5","key":"2026043011220900100_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2026043011220900100_bib32","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood-2009-09-244772","article-title":"A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy","volume":"115","author":"Chow","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2026043011220900100_bib33","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2012-02-413526","article-title":"Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia","volume":"120","author":"Aslam","year":"2012","journal-title":"Blood"},{"key":"2026043011220900100_bib34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"issue":"suppl 1","key":"2026043011220900100_bib35","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1053\/j.seminhematol.2013.03.018","article-title":"CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia","volume":"50","author":"Nishimoto","year":"2013","journal-title":"Semin Hematol"},{"issue":"2","key":"2026043011220900100_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.2006.00780.x","article-title":"Abnormality of CD4+CD25+ regulatory T cells in idiopathic thrombocytopenic purpura","volume":"78","author":"Liu","year":"2007","journal-title":"Eur J Haematol"},{"issue":"6","key":"2026043011220900100_bib37","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"2","key":"2026043011220900100_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J Clin Med"},{"issue":"13","key":"2026043011220900100_bib39","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.7150\/ijbs.33779","article-title":"Disrupted balance of CD4+ T-cell subsets in bone marrow of patients with primary immune thrombocytopenia","volume":"15","author":"Wang","year":"2019","journal-title":"Int J Biol Sci"},{"issue":"7","key":"2026043011220900100_bib40","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response","volume":"103","author":"Panitsas","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2026043011220900100_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12865-017-0210-3","article-title":"The cytokine polymorphisms affecting Th1\/Th2 increase the susceptibility to, and severity of, chronic ITP","volume":"18","author":"Takahashi","year":"2017","journal-title":"BMC Immunol"},{"issue":"10","key":"2026043011220900100_bib42","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","article-title":"Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity","volume":"87","author":"Semple","year":"1996","journal-title":"Blood"},{"issue":"8","key":"2026043011220900100_bib43","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.2020008477","article-title":"Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia","volume":"138","author":"Han","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2026043011220900100_bib44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/bjh.19083","article-title":"Pathogenesis of refractory ITP: overview","volume":"203","author":"Cines","year":"2023","journal-title":"Br J Haematol"},{"issue":"5","key":"2026043011220900100_bib45","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood-2006-02-004747","article-title":"IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo","volume":"108","author":"Zorn","year":"2006","journal-title":"Blood"},{"issue":"8","key":"2026043011220900100_bib46","doi-asserted-by":"crossref","first-page":"112996","DOI":"10.1016\/j.celrep.2023.112996","article-title":"IL-2 can signal via chemokine receptors to promote regulatory T cells' suppressive function","volume":"42","author":"Sun","year":"2023","journal-title":"Cell Rep"},{"issue":"6","key":"2026043011220900100_bib47","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"2026043011220900100_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2021.12.012","article-title":"Metabolic adaptation of lymphocytes in immunity and disease","volume":"55","author":"Chapman","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"2026043011220900100_bib49","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41467-023-36594-x","article-title":"Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming","volume":"14","author":"Aso","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"2026043011220900100_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2023.12.016","article-title":"Lysine acetyltransferase 6A maintains CD4+ T cell response via epigenetic reprogramming of glucose metabolism in autoimmunity","volume":"36","author":"Fu","year":"2024","journal-title":"Cell Metab"},{"issue":"1","key":"2026043011220900100_bib51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","article-title":"Metabolic coordination of T cell quiescence and activation","volume":"20","author":"Chapman","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2026043011220900100_bib52","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1084\/jem.20180397","article-title":"Metabolic control of regulatory T cell stability and function by TRAF3IP3 at the lysosome","volume":"215","author":"Yu","year":"2018","journal-title":"J Exp Med"},{"issue":"9","key":"2026043011220900100_bib53","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/febs.15853","article-title":"Metabolic rewiring: a new master of Th17 cell plasticity and heterogeneity","volume":"289","author":"Papadopoulou","year":"2022","journal-title":"FEBS J"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/18\/2114\/2514913\/blood_bld-2025-031332-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/18\/2114\/2514913\/blood_bld-2025-031332-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:22:21Z","timestamp":1777562541000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/18\/2114\/566893\/CDK8-CDK19-inhibition-restores-T-cell-homeostasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":53,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031332","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,30]]},"published":{"date-parts":[[2026,4,30]]}}}